Evaluation of Gliomas with Magnetic Resonance Fingerprinting with PET Correlation-A Comparative Study

Wolfgang Marik1, Pedro Lima Cardoso2, Elisabeth Springer2,3

  • 1Division of Neuroradiology and Musculoskeletal Radiology, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria.

Cancers
|June 22, 2023
PubMed
Abstract

Insights

MR fingerprinting (MRF) and PET offer quantitative insights into glioma characteristics. MRF shows good predictability for tumor regions and grading, though results differ from PET, highlighting distinct imaging mechanisms.

Area of Science:

  • Neuroimaging
  • Oncology
  • Radiology

Background:

  • Advanced brain tumor imaging relies on qualitative MRI.
  • Positron Emission Tomography (PET) provides metabolic information.
  • MR fingerprinting (MRF) enables novel quantitative data acquisition.

Purpose of the Study:

  • To assess MRF's ability to predict glioma regions and grade.
  • To evaluate MRF in combination with PET for brain tumor characterization.
  • To compare quantitative data from MRF and PET.

Main Methods:

  • Seventeen patients with infiltrating gliomas underwent MRF and amino-acid PET.
  • Regions of interest (ROIs) included solid tumor parts, edema, and white matter.
  • Predictability by region and grade, plus intermodal correlations, were analyzed.

Main Results:

  • MRF demonstrated high predictability for normal white matter (94.1%) and solid tumor parts (76.5%).
  • MRF distinguished low-grade from high-grade gliomas with 82.4% accuracy.
  • PET positivity was observed in solid tumor parts but showed no significant correlation with MRF values.

Conclusions:

  • MRF and PET provide valuable quantitative measurements for glioma tissue characteristics.
  • MRF exhibits good predictability for tumor regions and grading.
  • The dissimilar results between MRF and PET reflect their different underlying imaging mechanisms.